Allarity Therapeutics, Inc. (ALLR) Operating cash flow 2020–2025
Allarity Therapeutics, Inc. (ALLR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$14.8MFY2025 · since FY2020: -$7.3M → -$14.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.8M | +14.6% |
| FY2024 | -$17.4M | -36.1% |
| FY2023 | -$12.7M | +24.2% |
| FY2022 | -$16.8M | -13.0% |
| FY2021 | -$14.9M | -105.3% |
| FY2020 | -$7.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice